Oct 17
T2 Biosystems Announces Strategic Investment and Technology Development Agreement with In-Q-Tel (Centre Daily Times)
T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced a strategic investment and technology advancement agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. …